Another candidate target that plays a multifaceted role is xCT, as it is involved in acquisition/maintenance of most of the “hallmarks of cancer” and is overexpressed in various cancer types, including OSA, where its expression inversely correlates with overall survival [20,56]. This evidence concerns the gene SLC7A11 and obstructive sleep apnea syndrome.